Key result
Reversible cardiac remodeling signatures in pythons offer potential biomimetic targets for human heart disease.
Why the study?
To understand reversible cardiac remodeling and adaptive physiological cardiac hypertrophy by reviewing molecular signatures in vertebrates with extreme physiological adaptations, such as pythons, and exploring biomimetic therapeutics for human heart disease.
Understanding the molecular mechanisms of reversible physiological cardiac hypertrophy in extreme vertebrate adapters may provide novel biomimetic therapeutic targets for human heart disease.
Some vertebrates evolved to have a remarkable capacity for anatomical and physiological plasticity in response to environmental challenges. One example of such plasticity can be found in the ambush-hunting snakes of the genus Python, which exhibit reversible cardiac growth with feeding. The predation strategy employed by pythons is associated with months-long fasts that are arrested by ingestion of large prey. Consequently, digestion compels a dramatic increase in metabolic rate and hypertrophy of multiple organs, including the heart. In this Review, we summarize the post-prandial cardiac adaptations in pythons at the whole-heart, cellular and molecular scales. We highlight circulating factors and cellular signaling pathways that are altered during digestion to affect cardiac form and function and propose possible mechanisms that may drive the post-digestion regression of cardiac mass. Adaptive physiological cardiac hypertrophy has also been observed in other vertebrates, including in fish acclimated to cold water, birds flying at high altitudes and exercising mammals. To reveal potential evolutionarily conserved features, we summarize the molecular signatures of reversible cardiac remodeling identified in these species and compare them with those of pythons. Finally, we offer a perspective on the potential of biomimetics targeting the natural biology of pythons as therapeutics for human heart disease.
No takes yet. Share an insight, caveat, or question.
Martin et al. (2024) conducted a review in Reversible cardiac remodeling. Evolutionarily conserved molecular signatures of reversible cardiac remodeling in pythons and other vertebrates offer potential biomimetic therapeutic targets for human heart disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: